Chronic trazodone treatment consolidates sleep, improves memory, and reduces amyloid pathology in a mouse model of Alzheimer's disease
Arai, M.; Yue, J.; Shams, E.; Stevens, C. J.; Han, H.; Gibson, R.; Yildirim, T.; Feldman, H. H.; Wellington, C. L.; Kent, B. A.
Show abstract
Sleep disturbance in Alzheimer's disease (AD), particularly the reduction of slow wave sleep (SWS), has been proposed as a novel therapeutic target, with disease-modifying potential. Trazodone, an antidepressant with robust SWS-promoting properties, is currently the most prescribed sleep-promoting medication in the United States. Here, we demonstrate that chronic trazodone administration consolidates sleep in the APP NL-F knock-in mouse model of AD, increasing NREM sleep duration and slow wave power during the rest phase while promoting wake during the active phase. These sleep consolidating effects were accompanied by lower regional glial activation and amyloid burden, particularly in male mice. Most notably, hippocampal amyloid plaque burden was 45% lower in mice treated from 14 to 16 months of age than in vehicle-treated controls. Chronic trazodone treatment was also associated with better short-term and long-term recognition memory. Together, these findings support the potential of repurposing trazodone as a well-tolerated, disease-modifying therapeutic for AD, capable of enhancing sleep quality, improving cognition, and lowering AD-relevant neuropathology.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimers Disease 94%
- Microglial and Astrocyte priming in the APP/PS1 model of Alzheimer’s Disease: increased vulnerability to acute inflammation and cognitive deficits 93%
- Impact of early locus coeruleus lesions in the TgF344 Alzheimer's disease rat model 93%
Similar papers in this journal
- D-Methionine Improves Spatial Navigation and Attenuates Oxidative Stress and Amyloid Pathology in a Sex-Specific Manner 95%
- Altered Hippocampal Glutamatergic Neurotransmission and Cognitive Impairment in APP Knock-In Mice 94%
- Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer's disease 93%
Similar papers in this journal
- Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer's disease-related phenotypes 93%
- Sleep spindle architecture associated with distinct clinical phenotypes in older adults at risk for dementia 92%
- Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer's disease 92%
Similar papers in this journal
- Glycated alpha-synuclein assemblies cause distinct Parkinsons disease pathogenesis in mice 91%
- An exploratory study of gastrointestinal redox biomarkers in the presymptomatic and symptomatic Tg2576 mouse model of familial Alzheimer's disease - phenotypic correlates and the effects of chronic oral D-galactose 90%
- Divergent age-dependent conformational rearrangement within Aβ-amyloid deposits in APP23, APPPS1, and AppNL-F mice 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.